Eva Steinman invests in healthcare technology as an investing partner on Andreessen Horowitz’s Bio + Health team. She previously backed early-stage healthcare, technology, and consumer companies at Left Lane Capital after beginning in investment banking and trading at Morgan Stanley.

Unclaimed profile

Eva Steinman invests in healthcare technology as an investing partner on Andreessen Horowitz’s Bio + Health team. She previously backed early-stage healthcare, technology, and consumer companies at Left Lane Capital after beginning in investment banking and trading at Morgan Stanley.

Career

Eva Steinman holds a BA, Financial Economics from Columbia University.

Investing Partner, Bio + Health at Andreessen Horowitz (a16z) from 2025 to PresentFocuses on healthcare technology investments.
Investor at Left Lane Capital from 2023 to 2025Partnered with early-stage founders across healthcare, technology, and consumer companies.
Equities Trader and Investment Banking Analyst at Morgan Stanley from 2021 to 2023Began in equities trading and later worked in investment banking.
Growth at Geneva from 2020 to 2021Worked part-time on growth for the community platform.
Venture Fellow at NEA from 2019 to 2020
a16z.com

Investing in Telepatia

With Daisy Wolf and Gabriel Vasquez, explains the case for an AI-native clinical platform serving Latin American health systems.

Open ↗
a16z.com

Investing in Protege AI

With Daisy Wolf, examines the market for high-quality real-world data that advanced AI models need.

Open ↗
Media appearance

Building the Marketplace for AI’s Most Valuable Asset

With Daisy Wolf and Protege co-founder Bobby Samuels, discusses real-world data, model training, and evaluation datasets.

a16z.com · Open ↗
a16z.com

Investing in Ease

With Daisy Wolf and Anish Acharya, makes the case for an AI-native operating system unifying behavioral-health admissions, care, and billing.

Open ↗

Eva's Collections

Eva's Lists

In these lists

Cosigns Given